JP2021510715A5 - - Google Patents

Info

Publication number
JP2021510715A5
JP2021510715A5 JP2020539240A JP2020539240A JP2021510715A5 JP 2021510715 A5 JP2021510715 A5 JP 2021510715A5 JP 2020539240 A JP2020539240 A JP 2020539240A JP 2020539240 A JP2020539240 A JP 2020539240A JP 2021510715 A5 JP2021510715 A5 JP 2021510715A5
Authority
JP
Japan
Prior art keywords
iron
artemisinin
use according
leukemia
arsenic trioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020539240A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021510715A (ja
Filing date
Publication date
Priority claimed from GBGB1800736.9A external-priority patent/GB201800736D0/en
Application filed filed Critical
Publication of JP2021510715A publication Critical patent/JP2021510715A/ja
Publication of JP2021510715A5 publication Critical patent/JP2021510715A5/ja
Pending legal-status Critical Current

Links

JP2020539240A 2018-01-17 2019-01-17 白血病治療のための併用療法 Pending JP2021510715A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1800736.9 2018-01-17
GBGB1800736.9A GB201800736D0 (en) 2018-01-17 2018-01-17 Combination therapy for treatment of leukemia
PCT/GB2019/050124 WO2019141988A1 (en) 2018-01-17 2019-01-17 Combination therapy for treatment of leukemia

Publications (2)

Publication Number Publication Date
JP2021510715A JP2021510715A (ja) 2021-04-30
JP2021510715A5 true JP2021510715A5 (cg-RX-API-DMAC10.html) 2022-01-24

Family

ID=61256143

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020539240A Pending JP2021510715A (ja) 2018-01-17 2019-01-17 白血病治療のための併用療法

Country Status (6)

Country Link
US (1) US11400112B2 (cg-RX-API-DMAC10.html)
EP (1) EP3740215B1 (cg-RX-API-DMAC10.html)
JP (1) JP2021510715A (cg-RX-API-DMAC10.html)
CN (1) CN111818930A (cg-RX-API-DMAC10.html)
GB (1) GB201800736D0 (cg-RX-API-DMAC10.html)
WO (1) WO2019141988A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3138472C (en) * 2019-05-21 2024-05-07 Medsenic Use of metal ions to potentiate the therapeutic effects of arsenic
EP3868372A1 (en) * 2020-02-19 2021-08-25 JLP Health GmbH A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer
US11583552B2 (en) 2021-02-17 2023-02-21 Manoj Maniar Pharmaceutical formulation of arsenic trioxide
CN116687965B (zh) * 2023-05-05 2026-06-23 杭州市西溪医院 一种三氧化二砷-青蒿琥酯抗肿瘤组合物、双载药纳米脂质体及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04273819A (ja) * 1991-02-28 1992-09-30 Takeda Chem Ind Ltd 血圧上昇剤
CN1044559C (zh) * 1995-08-23 1999-08-11 哈尔滨医科大学附属第一医院 抗白血病、肝癌、淋巴瘤注射液
IL136051A0 (en) * 1997-11-10 2001-05-20 Sloan Kettering Inst Cancer Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
JP2005529938A (ja) * 2002-06-06 2005-10-06 ユニバーシティ オブ ワシントン 癌の発症を予防または遅延するためのアルテミシニン様化合物を使用する方法
JP2008201765A (ja) * 2007-01-26 2008-09-04 Jichi Medical Univ 腫瘍治療における三酸化二ヒ素の副作用低減剤及び解毒剤
CN102614168A (zh) * 2011-01-31 2012-08-01 上海交通大学医学院附属瑞金医院 一种青蒿素衍生物及其药用盐的应用
CN103202837B (zh) 2012-01-16 2015-05-13 上海交通大学医学院附属瑞金医院 青蒿素衍生物及其药用盐用于治疗制备白血病的药物
CN103202835B (zh) 2012-01-16 2015-05-13 上海交通大学医学院附属瑞金医院 青蒿素衍生物及其药用盐用于制备治疗急性白血病的药物
CN103202836B (zh) 2012-01-16 2015-05-13 上海交通大学医学院附属瑞金医院 青蒿素衍生物及其药用盐用于制备治疗急性髓细胞性白血病的药物
US9801851B2 (en) 2012-05-23 2017-10-31 St. Jude Children's Research Hospital Methods and compositions for the treatment of BCR-ABL positive lymphoblastic leukemias
CN103845360A (zh) * 2012-11-29 2014-06-11 昆明制药集团股份有限公司 含蒿甲醚的药物组合物、制剂及其用途
CN103845322A (zh) 2012-11-29 2014-06-11 昆明制药集团股份有限公司 蒿甲醚在制备治疗白血病的药物中的用途
CN104739824A (zh) 2013-12-30 2015-07-01 昆山达人生物医药有限公司 双氢青蒿素在制备抑制肿瘤生长药物中的应用
EP3233918A1 (en) * 2014-12-19 2017-10-25 Novartis AG Combination therapies
US9918972B2 (en) 2014-12-23 2018-03-20 The University Of Maryland, Baltimore Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents
US10925963B2 (en) 2015-06-22 2021-02-23 Washington University Combination artemisinin and chemiluminescent photodynamic therapy and uses therefor

Similar Documents

Publication Publication Date Title
JP2023541430A5 (cg-RX-API-DMAC10.html)
JP2022180461A5 (cg-RX-API-DMAC10.html)
JP2021512121A5 (cg-RX-API-DMAC10.html)
JP2024516795A5 (cg-RX-API-DMAC10.html)
JP2024516363A5 (cg-RX-API-DMAC10.html)
JP2006504723A5 (cg-RX-API-DMAC10.html)
JP2014512356A5 (cg-RX-API-DMAC10.html)
RU2020107416A (ru) Комбинация, содержащая палбоциклиб и 6-(2,4-дихлорфенил)-5-[4-[(3s)-1-(3-фторпропил)пиррролидин-3-ил]-8,9-дигидро-7h-бензо[7]аннулен-2-карбоновую кислоту, и ее применение для лечения рака
JP2010525050A5 (cg-RX-API-DMAC10.html)
JP2010270124A5 (cg-RX-API-DMAC10.html)
JP2020521797A5 (cg-RX-API-DMAC10.html)
JP2013520971A5 (cg-RX-API-DMAC10.html)
JP2005535606A5 (cg-RX-API-DMAC10.html)
JP2011515481A5 (cg-RX-API-DMAC10.html)
JP2012524089A5 (cg-RX-API-DMAC10.html)
JP2013518124A5 (cg-RX-API-DMAC10.html)
JP2005511597A5 (cg-RX-API-DMAC10.html)
JP2023550149A5 (cg-RX-API-DMAC10.html)
JP2012515184A5 (cg-RX-API-DMAC10.html)
JP2018522028A5 (cg-RX-API-DMAC10.html)
JP2006500346A5 (cg-RX-API-DMAC10.html)
JP2009515901A5 (cg-RX-API-DMAC10.html)
JP2015507020A5 (cg-RX-API-DMAC10.html)
RU2018107930A (ru) Агонисты tlr4, их композиции и применение для лечения рака
JP2015518053A5 (cg-RX-API-DMAC10.html)